Qosay Ali Al-Balas (Qosay A Al-Balas, Qosay A E Al-Balas, Qosay Al-Balas)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Molecular Docking

Coronavirus Disease

Angiotensin Converting Enzyme

Top Venues

Molecules (Basel, Switzerland)

Pharmacy practice

Drug development research

Science and engineering ethics

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad H Fetian, Qosay Ali Al-Balas
Unraveling Potential Glyoxalase-I Inhibitors Utilizing Structure-Based Drug Design Techniques. Advances and applications in bioinformatics and chemistry : AABC 17 (2024)
Qosay Ali Al-Balas, Shoroq Altawalbeh, Carmela Rinaldi, Ibtihal Ibrahim
The practice of defensive medicine among Jordanian physicians: A cross sectional study. PloS one 18 (11) (2023)
Loai M Saadah, Ghina'a I Abu Deiab, Qosay Ali Al-Balas, Olivia Stephanie Hendra
Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model. Pharmacy practice 20 (4) (2022)
Suaad Abdallah Audat, Qosay Ali Al-Balas, Buthina Abdallah Al-Oudat, Mo'ad Jamil Athamneh, Amanda Bryant-Friedrich
Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors. Drug design, development and therapy 16 (2022)
Loai M Saadah, Ghina'a I Abu Deiab, Qosay Ali Al-Balas, Olivia Stephanie Hendra
Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model. Pharmacy practice 20 (4) (2022)
Qosay Ali Al-Balas, Wael K Al-Delaimy
An Ethical Roadmap for Prioritizing Medical Resources Within Muslim Societies During the COVID-19 Pandemic. Journal of religion and health 60 (5) (2021)
Loai M Saadah, Ghina'a I Abu Deiab, Qosay Ali Al-Balas, Iman A Basheti
Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein. Molecules (Basel, Switzerland) 25 (23) (2020)
Suaad Abdallah Audat, Nizar A Al-Shar'i, Buthina A Al-Oudat, Amanda Bryant-Friedrich, Mel F Bedi, Aref L Zayed, Qosay Ali Al-Balas
Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking. Molecules (Basel, Switzerland) 25 (12) (2020)
Qosay Ali Al-Balas, Rana Dajani, Wael K Al-Delaimy
The Ethics of Gene Editing from an Islamic Perspective: A Focus on the Recent Gene Editing of the Chinese Twins. Science and engineering ethics 26 (3) (2020)
Qosay Ali Al-Balas, Mousa L Al-Smadi, Mohammad A Hassan, Ghazi A Al Jabal, Ammar M Almaaytah, Karem H Alzoubi
Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors. Molecules (Basel, Switzerland) 24 (18) (2019)
Ammar M Almaaytah, Ahmad Farajallah, Ahmad Abualhaijaa, Qosay Ali Al-Balas
A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria. Molecules (Basel, Switzerland) 23 (7) (2018)
Ammar M Almaaytah, Mohammed T Qaoud, Gubran Khalil Mohammed, Ahmad Abualhaijaa, Daniel Knappe, Ralf Hoffmann, Qosay Ali Al-Balas
Antimicrobial and Antibiofilm Activity of UP-5, an Ultrashort Antimicrobial Peptide Designed Using Only Arginine and Biphenylalanine. Pharmaceuticals (Basel, Switzerland) 11 (1) (2018)
Qosay Ali Al-Balas, Mohammad A Hassan, Nizar A Al-Shar'i, Tamam El-Elimat, Ammar M Almaaytah
Computational and experimental exploration of the structure-activity relationships of flavonoids as potent glyoxalase-I inhibitors. Drug development research 79 (2) (2017)